Comparison of polystyrene nanoparticles and UV-inactivated antigen-displaying adenovirus for vaccine delivery in mice

Virology Journal

Volumn 10, Issue , 2013, Pages

  Johrden, Lena ^a   Tenbusch, Matthias ^a   Lietz, Ruth ^a   Bonsmann, Michael Storcksdieck Genannt ^a   Niezold, Thomas ^a   Wildner, Oliver ^a,c   Bayer, Wibke ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Adenovirus; Nanoparticles; Ovalbumin; Polystyrene; Vaccination

Indexed keywords

ANTIBODY; NANOPARTICLE; OVALBUMIN; POLYSTYRENE; VACCINE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PARTICLE SIZE; ULTRAVIOLET RADIATION;

ADENOVIRIDAE; MUS;

EID: 84875847043     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-108     Document Type: Article

References (16)

1. Aluminum salts in vaccines-US perspective. Baylor NW, Egan W, Richman P, Vaccine 2002 20 Suppl 3 18 S23 12184360
2. Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity. Kalkanidis M, Pietersz GA, Xiang SD, Mottram PL, Crimeen-Irwin B, Ardipradja K, Methods 2006 40 20 29 10.1016/j.ymeth.2006.05.018 16997710
3. Nanotechnology in vaccine delivery. Peek LJ, Middaugh CR, Berkland C, Adv Drug Deliv Rev 2008 60 915 928 10.1016/j.addr.2007.05.017 18325628
4. Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, O'Neil CP, Nat Biotechnol 2007 25 1159 1164 10.1038/nbt1332 17873867
5. Vaccination with an adenoviral vector that encodes and displays a retroviral antigen induces improved neutralizing antibody and CD4+ T-cell responses and confers enhanced protection. Bayer W, Tenbusch M, Lietz R, Johrden L, Schimmer S, Uberla K, J Virol 2010 84 1967 1976 10.1128/JVI.01840-09 20007267
6. Polysciences Inc. Technical Data Sheet 238C, Covalent coupling of proteins to carboxylated polystyrene microparticles by the " carbodiimide" method Fishers, IN: Polysciences Inc 2009
7. Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity. Tenbusch M, Kuate S, Tippler B, Gerlach N, Schimmer S, Dittmer U, BMC Immunol 2008 9 13 10.1186/1471-2172-9-13 18405363
8. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Cobbold SP, Jayasuriya A, Nash A, Prospero TD, Waldmann H, Nature 1984 312 548 551 10.1038/312548a0 6150440
9. Molecular basis of the inflammatory response to adenovirus vectors. Liu Q, Muruve DA, Gene Ther 2003 10 935 940 10.1038/sj.gt.3302036 12756413
10. High-efficiency receptor-mediated delivery of small and large 48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Cotten M, Wagner E, Zatloukal K, Phillips S, Curiel DT, Birnstiel ML, Proc Natl Acad Sci USA 1992 89 6094 6098 10.1073/pnas.89.13.6094 1352882
11. Exact prediction of a natural T cell epitope. Rotzschke O, Falk K, Stevanovic S, Jung G, Walden P, Rammensee HG, Eur J Immunol 1991 21 2891 2894 10.1002/eji.1830211136 1718764
12. Antigenic and allergenic determinants of ovalbumin-III. MHC Ia-binding peptide (OA 323-339) interacts with human and rabbit specific antibodies. Johnsen G, Elsayed S, Mol Immunol 1990 27 821 827 10.1016/0161-5890(90)90147-R 1699119
13. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Bachmann MF, Jennings GT, Nat Rev Immunol 2010 10 787 796 10.1038/nri2868 20948547
14. Nanoparticles target distinct dendritic cell populations according to their size. Manolova V, Flace A, Bauer M, Schwarz K, Saudan P, Bachmann MF, Eur J Immunol 2008 38 1404 1413 10.1002/eji.200737984 18389478
15. AS03 Adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, Sundman J, PLoS One 2012 7 33536 10.1371/journal.pone. 0033536 22470453
16. Adjuvants and autoimmunity. Israeli E, Gmon-Levin N, Blank M, Shoenfeld Y, Lupus 2009 18 1217 1225 10.1177/0961203309345724 19880572